Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Condition: Prostatic NeoplasmsIntervention: Drug: Radium-223 dichloride (BAY88-8223)Sponsor: BayerActive, not recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hormone Refractory Prostate Cancer | Hormones | Prostate Cancer | Research